Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells

Cancer Letters

Volumn 189, Issue 1, 2003, Pages 17-25

  Pham, Hung ^a   Banerjee, Tinku ^a   Nalbandian, Gregory M ^a   Ziboh, Vincent A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

15S Hydroxyeicosatrienoic acid; Dihydrotestosterone; Gamma linolenic acid; Peroxisome proliferator activated receptor gamma; Prostate cancer

Indexed keywords

15S HYDROXYEICOSATRIENOIC ACID; ANDROGEN; ARACHIDONATE 15 LIPOXYGENASE; CELL NUCLEUS RECEPTOR; GAMMA LINOLENIC ACID; ICOSATRIENOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; THYMIDINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; GROWTH INHIBITION; IN VIVO STUDY; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; RAT; UPREGULATION;

ADENOCARCINOMA; CELL DIVISION; DIHYDROTESTOSTERONE; EICOSANOIC ACIDS; FLOW CYTOMETRY; GAMMA-LINOLENIC ACID; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0037427559     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00498-6     Document Type: Article

References (29)

1. Cunha G.R., Donjacour A.A., Cooke P.S., Mee S., Bigsby R.M., Higgins S.J., Sugimura Y. The endocrinology and developmental biology of the prostate. Endocrinol. Rev. 8:1987;338-362.
2. Bruchovsky N., Rennie P.S., Batzold F.H., Goldenberg S.L., Fletcher T., McLoughlin M.G. Kinetic parameters of 5α-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J. Clin. Endocrinol. Metab. 67:1988;806-816.
3. Wilding G. The importance of steroid hormones in prostate cancer. Cancer Surv. 14:1992;113-130.
4. Ford L.G., Brawley O.W., Perlman J.A., Nayfield S.G., Johnson K.A., Kramer B.S. The potential for hormonal prevention trials. Cancer. 74:1994;2726-2733.
5. Liang T., Liaos S. Inhibition of steroid 5α-reductase by specific aliphatic unsaturated fatty acids. Biochem. J. 285:1992;557-562.
6. Liao S. Androgen action: molecular mechanism and medical application. J. Formosan Med. Assoc. 93:1994;741-751.
7. Neiderprum H.J., Schweikert H.U., Thuroff J.W., Zanker K.S. Inhibition of steroid 5α-reductase activity by aliphatic fatty acids: candidates for chemoprevention of prostate cancer. Ann. N. Y. Acad. Sci. 768:1995;227-230.
8. Liang T., Liao S. Growth suppression of hamster flank organs by topical application of γ-linolenic and other fatty acid inhibitors of 5α-reductase. J. Invest. Dermatol. 109:1997;152-157.
9. Robbins M., Ali K., McCaw R., Olsen J., Vartak S., Lubaroff D. γ-Linolenic acid (GLA)-mediated cytotoxicity in human prostate cancer cells. Adv. Exp. Med. Biol. 469:1999;499-504.
10. Bergstrom S., Danielsson H., Klenberg D., Samuelsson B. The enzymatic conversion of essential fatty acids into prostaglandins. J. Biol. Chem. 239:1964;4006-4008.
11. Borgeat P., Hamberg M., Samuelsson S. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes: monohydroxy acids from novel lipoxygenase. J. Biol. Chem. 251:1976;7816-7820.
12. Miller C.C., Ziboh V.A. Gammalinolenic acid-enriched diet alters cutaneous eicosanoids. Biochem. Biophys. Res. Commun. 154:1988;967-974.
13. Xi S., Pham H., Ziboh V.A. Suppression of proto-oncogene (AP-1) in a model of skin epidermal hyperproliferation is reversed by topical application of 13-hydroxyoctadecadienoic acid and 15-hydroxyeicosatrienoic acid. Prostaglandins Leukotrienes Essent. Fatty Acids. 62:2000;13-19.
14. Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:1996;907-925.
15. Park S., Sabourin C.L., Yee L., Sales J., Smith P. Activation of peroxisome proliferator-activated receptor-γ by γ-linolenic acid and other fatty acids in vitro in human breast cancer cells. Huang Y.S., Ziboh V.A., γ-Linolenic Acid: Recent Advances in Biotechnology and Clinical Applications. 2001;227-241 AOCS Press, Champaign, IL.
16. Isseman I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
17. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:1992;879-887.
18. Schmidt A., Endo N., Rutledge S.J., Vogel R., Shinar D., Rodan G.A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6:1992;1634-1641.
19. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA. 94:1997;4318-4323.
20. Jiang W.G., Redfern A., Bryce R.P., Mansel R.E. Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukotrienes Essent. Fatty Acids. 62:2000;119-127.
21. Shappell S.B., Gupta R.A., Manning S., Whitehead R., Boeglin W.E., Schneider C., Case T., Price J., Jack G.S., Wheeler T.M., Matusik R.J., Brash A.R., DuBois R.N. 15S-Hydroxyeicosatetraenoic acid (15S-HETE) activates peroxisome proliferator-activated receptor γ and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res. 61:2001;497-503.
22. Danielpour D., Kadomatsu K., Anzano M.A., Smith J.M., Sporn M.B. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res. 54:1994;3413-3421.
23. Miller C.C., Ziboh V.A. Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE). J. Invest. Dermatol. 94:1990;353-358.
24. Ricter F., Huang H.F.S., Li M.T., Danielpour D., Wang S.L., Irwin R.J. Retinoid and androgen regulation of cell growth, epidermal growth factor and retinoic acid receptors in normal and carcinoma rat prostate cell. Mol. Cell. Endocrinol. 153:1999;29-38.
25. Sato H., Ishihara S., Kawashima K., Moriyama N., Suetsugu H., Kazumori H., Okuyama T., Rumi M.A.K., Fukuda R., Nagasue N., Kinoshita Y. Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists. Br. J. Cancer. 83:2000;1394-1400.
26. Takashima T., Fujiwara Y., Higuchi K., Arakawa T., Yano Y., Hasuma T., Otani S. PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int. J. Oncol. 19:2001;465-471.
27. 2. Cell Growth Differ. 11:2000;49-61.
28. 2-I activity and possible PPAR activation at the nuclear level. FEBS Lett. 490:2000;88-92.
29. Shappell S.B., Boeglin W.E., Olson S.J., Kasper S., Brash A.R. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostatic adenocarcinoma. Am. J. Pathol. 155:1999;235-245.